Public Employees Retirement System of Ohio Cuts Position in IQVIA Holdings Inc. (NYSE:IQV)

Public Employees Retirement System of Ohio decreased its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 5.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 65,474 shares of the medical research company's stock after selling 3,961 shares during the quarter. Public Employees Retirement System of Ohio's holdings in IQVIA were worth $15,515,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. PGGM Investments lifted its position in shares of IQVIA by 55.8% during the second quarter. PGGM Investments now owns 12,073 shares of the medical research company's stock worth $2,553,000 after purchasing an additional 4,326 shares in the last quarter. Simplify Asset Management Inc. boosted its position in IQVIA by 67.8% in the 3rd quarter. Simplify Asset Management Inc. now owns 9,637 shares of the medical research company's stock valued at $2,284,000 after buying an additional 3,894 shares during the period. Raymond James & Associates grew its stake in shares of IQVIA by 0.7% in the second quarter. Raymond James & Associates now owns 800,374 shares of the medical research company's stock worth $169,231,000 after acquiring an additional 5,417 shares in the last quarter. Versor Investments LP purchased a new stake in shares of IQVIA during the third quarter worth $1,328,000. Finally, Gradient Investments LLC raised its stake in shares of IQVIA by 15.6% in the second quarter. Gradient Investments LLC now owns 45,401 shares of the medical research company's stock valued at $9,600,000 after acquiring an additional 6,134 shares in the last quarter. Institutional investors and hedge funds own 89.62% of the company's stock.

IQVIA Stock Performance

IQVIA stock traded down $2.15 during mid-day trading on Wednesday, reaching $201.05. 1,457,807 shares of the company were exchanged, compared to its average volume of 1,186,342. The firm has a market cap of $36.49 billion, a PE ratio of 26.39, a price-to-earnings-growth ratio of 2.08 and a beta of 1.49. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The firm's 50-day simple moving average is $214.01 and its two-hundred day simple moving average is $224.77. IQVIA Holdings Inc. has a twelve month low of $187.62 and a twelve month high of $261.73.

Analyst Ratings Changes

IQV has been the topic of several recent research reports. Leerink Partners restated an "outperform" rating and set a $248.00 price target (down previously from $260.00) on shares of IQVIA in a report on Tuesday, November 19th. BTIG Research reduced their target price on shares of IQVIA from $290.00 to $260.00 and set a "buy" rating on the stock in a report on Friday, November 1st. The Goldman Sachs Group decreased their price target on shares of IQVIA from $280.00 to $250.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Barclays reduced their price objective on shares of IQVIA from $260.00 to $255.00 and set an "overweight" rating on the stock in a report on Friday, November 1st. Finally, Robert W. Baird lowered their target price on shares of IQVIA from $213.00 to $212.00 and set a "neutral" rating for the company in a research note on Wednesday. Five equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $255.81.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.